Sign in
Lower extremity ecchymotic nodules in a patient being treated with ibrutinib for chronic lymphocytic leukemia
Journal article   Open access   Peer reviewed

Lower extremity ecchymotic nodules in a patient being treated with ibrutinib for chronic lymphocytic leukemia

Josh A Hammel, Gretchen M Roth, Nkanyezi Ferguson and Janet A Fairley
JAAD Case Reports, Vol.3(3), pp.178-179
04/14/2017
DOI: 10.1016/j.jdcr.2017.01.027
PMCID: PMC5396857
PMID: 28459097
pdf
Lower extremity ecchymotic nodules in a patient being treated wit412.42 kBDownloadView
Published (Version of record)CC BY-NC-ND V4.0 Open Access
url
https://doi.org/10.1016/j.jdcr.2017.01.027View
Published (Version of record)JAAD Case Reports 3(3) May 2017, Pages 178-179.

Abstract

Ibrutinib, an inhibitor of Bruton tyrosine kinase, is used in the treatment of lymphoid leukemias. Ibrutinib-induced panniculitis has been described as a rare cutaneous side effect. We describe a case of a septolobular, mixed inflammatory panniculitis with small-vessel vasculitis secondary to ibrutinib therapy.
Dermatology Oncology Tuberculosis OAfund ibrutinib panniculitis TB

Details

Metrics

104 File views/ downloads
76 Record Views